Bacterium Preserved in 5,000-Year-Old Cave Ice Resists Modern Antibiotics

A bacterium sealed in Romanian cave ice before the pyramids were built resists drugs that humans wouldn’t invent for another 5,000 years. The discovery adds to growing evidence that antibiotic resistance long predates modern medicine, challenging the narrative that resistance stems mainly from overuse in hospitals and agriculture.

Scientists pulled Psychrobacter SC65A.3 from Scărișoara Ice Cave, extracting it from ice layers dated to approximately 5,335 years old. When researchers tested the ancient microbe against 28 different antibiotics in the lab, it resisted 10 of them: including powerful drugs doctors rely on when common antibiotics fail. Because no clinical testing standards exist for Psychrobacter species, researchers applied guidelines from related bacteria, so these classifications should be viewed cautiously. Still, genome analysis identified 107 genes associated with antimicrobial resistance, a pharmaceutical defense system that evolved millennia before humans discovered penicillin in 1928.

The findings, published in Frontiers in Microbiology, don’t excuse modern antibiotic overuse, which has dramatically accelerated resistance. But they reinforce evidence that the evolutionary arms race between microbes began long before humans entered the picture.

Ancient Bacterium Inhibits Several Modern Pathogens

Here’s where the story takes an unexpected turn. This antibiotic-resistant ancient bacterium also inhibits growth of other bacteria, including some of today’s most dangerous hospital pathogens.

Researchers pitted SC65A.3 against 22 different microbes. It inhibited 14 of them, including one strain of methicillin-resistant Staphylococcus aureus (MRSA), along with multiple strains of Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterobacter species. These pathogens belong to a group doctors call ESKAPE because they “escape” most drugs and cause difficult-to-treat infections.

How can one bacterium resist antibiotics while producing them? The answer lies in microbial warfare. In the resource-starved environment of an ice cave, bacteria compete fiercely for survival. Producing antimicrobial compounds kills rivals for limited nutrients. But launching chemical weapons creates new evolutionary pressure: bacteria must protect themselves from their own arsenal and that of their competitors. This back-and-forth has been running for millions of years.

Modern antibiotic use hasn’t created resistance. It’s amplified an ancient process, taking slow evolution and putting it into overdrive through intense selection pressure.

5,000 Years in Deep Freeze

Scărișoara Ice Cave houses one of Earth’s oldest underground ice blocks. Some ice dates back 13,000 years. The cave maintains near-freezing temperatures year-round, creating a time capsule that preserves ancient life. Scientists have found viable bacteria throughout the ice, meaning microbes remained alive or dormant across millennia.

Researchers drilled deep into the ice, about 17 meters down. When they warmed samples at 4°C, orange-pink bacterial colonies appeared. Tests showed SC65A.3 thrives in extreme cold (between 4°C and 15°C) and survives in salt concentrations higher than ocean water. The bacterium qualifies as what scientists call a polyextremophile, an organism adapted to multiple harsh conditions.

Why Prehistoric Bacteria Resists Modern Drugs

The deeper mystery: Why would a cave ice bacterium carry genes defending against antibiotics chemically unrelated to anything in its environment?

Take the mcr-1 gene, which is associated with resistance to colistin, derived from soil bacteria living in completely different habitats. The presence of genes associated with colistin resistance raises questions about how such determinants evolved in isolated environments.

Many resistance mechanisms work broadly rather than targeting just one drug. Some resistance genes destroy ring-shaped molecules found in many natural compounds, not just pharmaceutical penicillins. Others work like microscopic pumps, simply ejecting toxic molecules from cells. These pumps evolved to handle environmental toxins but happen to work on antibiotics too.

When humans discovered antibiotics, we weren’t inventing new chemistry. We were borrowing weapons bacteria had been using for millions of years.

From Ice Cave to Medicine Cabinet

The bacterium’s ability to inhibit dangerous pathogens suggests potential medical promise. As resistance spreads and pharmaceutical companies struggle to develop new drugs, scientists desperately need fresh sources of antimicrobial compounds.

SC65A.3 inhibited one MRSA strain and stopped Pseudomonas aeruginosa, a common culprit in ventilator pneumonia and burn infections. It also worked against Klebsiella pneumoniae, increasingly resistant to our most powerful drugs. These aren’t academic curiosities, they’re real clinical nightmares.

Cave environments may harbor microorganisms isolated from mainstream evolution for thousands of years, potentially producing unique chemical structures different from known antibiotics. About 23 percent of SC65A.3’s genes remain unidentified, scientists don’t know what they do. Some may encode completely novel compounds.

The bacterium also produces enzymes that function in extreme cold, valuable for industrial processes that operate at low temperatures. Its ability to break down long-chain fatty acids could prove useful for biodiesel production or cold-water detergents.

Climate Change’s Hidden Archive

Ice caves remain relatively unexplored compared to other cold environments. But as climate change accelerates glacier and permafrost thaw globally, ancient microorganisms will increasingly interact with modern ecosystems. Bacteria frozen for millennia carry genes that could potentially transfer to modern pathogens through natural genetic exchange between bacterial species. Direct transfer from cave bacteria to hospital pathogens remains theoretical, but environmental reservoirs of resistance genes are increasingly studied.

Comparison with other bacteria from Arctic ice cores, Antarctic seawater, and marine sediments showed SC65A.3 demonstrated resistance to more antibiotics than closely related strains tested under similar conditions. To our knowledge, this is the first genome analysis of a Psychrobacter isolate from cave ice and the first description of an ancient resistome from this habitat.

The findings document baseline resistance mechanisms that existed before human antibiotic use began. In other words, a genetic snapshot of microbial evolution frozen in time and preserved in underground ice for five millennia.

---

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The research described involves laboratory findings and does not constitute medical recommendations. Always consult qualified healthcare providers regarding antibiotic use and treatment decisions.

---